Literature DB >> 17308960

Gene expression profiling in human null cell pituitary adenoma tissue.

Ji Hu1, Huaidong Song, Xuanchun Wang, Ye Shen, Fengling Chen, Yu Liu, Shiqi Li, Yongfei Wang, Xuefei Shou, Yulin Zhang, Renming Hu.   

Abstract

It is estimated that up to one in five individuals develops pituitary gland tumors, despite the common occurrence of these tumors, the pathogenetic mechanisms underlying their development mainly remain unknown. We studied the gene expression in null cell adenomas compared with normal pituitary by expressed sequence tags (EST) sequencing and cDNA microarray on large scale. Both approaches of EST sequencing and microarray analysis showed that 17 genes were differentially expressed in human null cell pituitary adenoma tissues, among which 14 genes were overexpressed and three genes were underpressed. Five of the genes with potential oncogenic significance by RT-real time quantitative PCR. Synaptotagmin (SYT) are integral membrane proteins of synaptic vesicles considered to serve as Ca(2+) sensors in the process of vesicular trafficking and exocytosis. Calcium binding to participates in triggering neurotransmitter release at the synapse. In view of our finding that SYT is overexpressed in null cell adenomas, these tumors may be capable of secreting some unknown hormones or peptides. ATP5B and MDH1 were involved in the energy metabolism, whose overexpression in null cell adenomas provide us with a new perspective of exploring the oncogenesis of these tumors. All of these data may contribute to the understanding of null cell adenoma formation and development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308960     DOI: 10.1007/s11102-007-0008-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  9 in total

1.  Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning.

Authors:  R M Hu; Z G Han; H D Song; Y D Peng; Q H Huang; S X Ren; Y J Gu; C H Huang; Y B Li; C L Jiang; G Fu; Q H Zhang; B W Gu; M Dai; Y F Mao; G F Gao; R Rong; M Ye; J Zhou; S H Xu; J Gu; J X Shi; W R Jin; C K Zhang; T M Wu; G Y Huang; Z Chen; M D Chen; J L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Synaptotagmin I functions as a calcium regulator of release probability.

Authors:  R Fernández-Chacón; A Königstorfer; S H Gerber; J García; M F Matos; C F Stevens; N Brose; J Rizo; C Rosenmund; T C Südhof
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

3.  Molecular cloning and mapping of a human cDNA for cytosolic malate dehydrogenase (MDH1).

Authors:  T Tanaka; J Inazawa; Y Nakamura
Journal:  Genomics       Date:  1996-02-15       Impact factor: 5.736

Review 4.  Classification of pituitary adenomas.

Authors:  K Kovacs; E Horvath; S Vidal
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 5.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Synaptotagmin I is necessary for compensatory synaptic vesicle endocytosis in vivo.

Authors:  Kira E Poskanzer; Kurt W Marek; Sean T Sweeney; Graeme W Davis
Journal:  Nature       Date:  2003-11-23       Impact factor: 49.962

7.  The human ATP synthase beta subunit gene: sequence analysis, chromosome assignment, and differential expression.

Authors:  N Neckelmann; C K Warner; A Chung; J Kudoh; S Minoshima; R Fukuyama; M Maekawa; Y Shimizu; N Shimizu; J D Liu
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

8.  Gene expression profiling in human insulinoma tissue: genes involved in the insulin secretion pathway and cloning of novel full-length cDNAs.

Authors:  X-C Wang; S-Y Xu; X-Y Wu; H-D Song; Y-F Mao; H-Y Fan; F Yu; B Mou; Y-Y Gu; L-Q Xu; X-O Zhou; Z Chen; J-L Chen; R-M Hu
Journal:  Endocr Relat Cancer       Date:  2004-06       Impact factor: 5.678

9.  A novel ligand in lymphocyte-mediated cytotoxicity: expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines.

Authors:  B Das; M O Mondragon; M Sadeghian; V B Hatcher; A J Norin
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

  9 in total
  3 in total

1.  Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.

Authors:  T Chile; M L Corrêa-Giannella; M A H Z Fortes; M D Bronstein; M B Cunha-Neto; D Giannella-Neto; R R Giorgi
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

Review 2.  Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies.

Authors:  Busra Aydin; Aysegul Caliskan; Kazim Yalcin Arga
Journal:  EPMA J       Date:  2021-06-26       Impact factor: 8.836

3.  Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles.

Authors:  Maria Francesca Cassarino; Alberto G Ambrogio; Andrea Cassarino; Maria Rosa Terreni; Davide Gentilini; Antonella Sesta; Francesco Cavagnini; Marco Losa; Francesca Pecori Giraldi
Journal:  J Neuroendocrinol       Date:  2018-08-07       Impact factor: 3.627

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.